Effects of repeated treatment with sodium 2,3-dimercaptopropane-1-sulfonate in beagle dogs.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002104:Cadmium / Q000378:metabolism; D003300:Copper / Q000378:metabolism; D004112:Dimercaprol / Q000031:analogs & derivatives*; D004285:Dogs; D004573:Electrolytes / Q000097:blood; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D007501:Iron / Q000378:metabolism; D008297:Male; D014494:Unithiol / Q000633:toxicity*; D015032:Zinc / Q000378:metabolism
D004573:Electrolytes; D006454:Hemoglobins; D002104:Cadmium; D004112:Dimercaprol; D014494:Unithiol; D003300:Copper; D007501:Iron; D015032:Zinc